1800-272-662
Shopping Cart 0
countryflagAU
Login

Curvebeam Ai Ltd

Healthcare AU CVB

0.061AUD
-(-%)

Last update at 2026-03-13T03:03:00Z

Day Range

0.060.06
LowHigh

52 Week Range

0.060.17
LowHigh

Fundamentals

  • Previous Close 0.06
  • Market Cap29.14M
  • Volume107010
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-12.00999M
  • Revenue TTM12.15M
  • Revenue Per Share TTM0.03
  • Gross Profit TTM 5.07M
  • Diluted EPS TTM-0.04

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Income before tax -16.84275M -23.10102M -51.22675M -9.62300M -6.74700M
Minority interest - - - - -
Net income -16.84275M -23.10102M -51.22675M -9.62300M -6.74700M
Selling general administrative 20.73M 18.02M 12.98M 9.37M 7.36M
Selling and marketing expenses - - - - -
Gross profit 5.43M 3.01M 4.39M 3.99M 3.22M
Reconciled depreciation - 2.83M 1.98M 0.46M 0.24M
Ebit - - - - -
Ebitda - - - - -
Depreciation and amortization - - - - -
Non operating income net other - - - - -
Operating income -16.84275M -23.93777M -18.75649M -11.99500M -7.62400M
Other operating expenses - - - - -
Interest expense 0.21M 1.64M 5.73M 0.12M 0.56M
Tax provision 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Interest income - 0.37M 0.04M - -
Net interest income - -1.26898M -5.69118M -0.12300M -0.56000M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - - - - -
Total revenue 12.10M 6.53M 8.06M 7.42M 7.20M
Total operating expenses 28.94M - - - -
Cost of revenue 6.67M 3.52M 3.66M 3.43M 3.98M
Total other income expense net - 2.11M -26.77908M 2.50M 1.44M
Discontinued operations - - - - -
Net income from continuing ops - -23.10102M -51.22675M -9.62300M -6.74700M
Net income applicable to common shares -16.84275M - - - -
Preferred stock and other adjustments - - - - -
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Total assets 60.98M 63.33M 61.36M 0.00000M 0.00000M
Intangible assets 16.43M 18.16M 20.54M - -
Earning assets - - - - -
Other current assets - 0.04M 0.16M - -
Total liab 25.87M 24.41M 109.46M 0.00000M 0.00000M
Total stockholder equity 35.11M 38.92M -48.10027M 0.00000M 0.00000M
Deferred long term liab - - - - -
Other current liab - 2.73M 31.15M - -
Common stock 136.65M - - - -
Capital stock - 125.10M 17.36M - -
Retained earnings -102.76129M -92.38881M -69.31360M - -
Other liab - - - - -
Good will 20.18M 20.18M 20.18M - -
Other assets 0.15M - - - -
Cash - 6.45M 5.16M - -
Cash and equivalents 5.04M - - - -
Total current liabilities 8.21M 8.17M 38.81M 0.00000M 0.00000M
Current deferred revenue - - - - -
Net debt - 8.64M 8.56M - -
Short term debt 1.03M - - - -
Short long term debt - 1.10M 1.07M - -
Short long term debt total - - - - -
Other stockholder equity 1.22M - - - -
Property plant equipment 2.64M - - - -
Total current assets 20.26M 23.36M 19.48M 0.00000M 0.00000M
Long term investments - 0.15M 0.02M - -
Net tangible assets - - - - -
Short term investments - - - - -
Net receivables 0.53M 2.04M 2.70M - -
Long term debt 14.49M 13.99M 12.64M - -
Inventory 10.26M 10.76M 8.66M - -
Accounts payable - 1.93M 2.42M - -
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - -
Deferred long term asset charges - - - - -
Non current assets total - 39.97M 41.89M 0.00000M 0.00000M
Capital lease obligations - 0.84M 1.13M - -
Long term debt total 16.02M - - - -
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Investments - -0.32382M -4.10077M -0.30600M -0.29500M
Change to liabilities - - - - -
Total cashflows from investing activities -0.48918M - - - -
Net borrowings - - - - -
Total cash from financing activities 10.31M 23.63M 22.25M 20.06M 4.52M
Change to operating activities - - - - -
Net income - -23.10102M -51.22675M -9.62300M -6.74700M
Change in cash -1.40730M 1.45M -3.52165M 9.56M -0.30500M
Begin period cash flow - 5.16M 8.70M 0.26M 0.57M
End period cash flow - 6.45M 5.16M 10.10M 0.26M
Total cash from operating activities -11.16959M - - - -
Issuance of capital stock - 24.98M 23.40M 2.10M 1.30M
Depreciation - - - - -
Other cashflows from investing activities - - - - -
Dividends paid - - - - -
Change to inventory - - - - -
Change to account receivables - - - - -
Sale purchase of stock 11.58M -1.80669M -0.13640M - -
Other cashflows from financing activities -1.03579M - - - -
Change to netincome - - - - -
Capital expenditures 0.49M 0.32M 0.84M 0.31M 0.29M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.23M - - - -
Stock based compensation - - - - -
Other non cash items - - - - -
Free cash flow - -22.18413M -22.51654M -10.50000M -4.82800M

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x)
CVB
Curvebeam Ai Ltd		 - -% 0.06 - - 2.40 0.81 3.52
COH
Cochlear Ltd		 -4.74 2.65% 174.42 33.10 26.39 4.88 6.04 5.59 23.13
4DX
4DMEDICAL Ltd		 -0.15 3.55% 4.07 - - 401.92 37.59 417.71 -7.2899
AVR
Anteris Technologies Global Corp		 - -% 9.10 - - 475.96 166.77 334.65 -5.1986
PNV
Polynovo Ltd		 - -% 0.94 94.00 30.21 4.66 7.81 4.68 93.96

Reports Covered

Stock Research & News

View All

Profile

CurveBeam AI Limited engages in the development and manufacture of point-of care specialized weight bearing medical imaging equipment in Europe, North America, and Australia. The company offers HiRise for bilateral weight bearing CT imaging; LineUP, a bilateral, weight bearing CT imaging of the knees and lower extremities for orthpedic practices; pedCAT Premium and pedCAT for imaging of the foot and ankle; InReach, a point-of-care extremity CT imaging which assess the distal extremities with 3D clarity at a fraction of the dose; and CubeVue Software visualization tools. It also provides software CurveBeam AI Autometrics for automatically segment foot and ankle datasets; Axiometrics, provides a semi-automatic measurement of the axes of rotation of the hip, femur, knee, and ankle; and TALAS, a measurement tool that semi-automatically calculate hindfoot alignment based on reproducible three-dimensional anatomical landmarks. In addition, the company offers custom web-based cloud platform; and OSSView. The company was incorporated in 2009 and is headquartered in Hatfield, Pennsylvania.

Curvebeam Ai Ltd

2800 Bronze Drive, Hatfield, PA, United States, 19440

Key Executives

Name Title Year Born
Mr. Gregory Brown BSc, MBA CEO, MD & Director 1964
Mr. Gregory Brown BSc, MBA CEO, MD & Director 1964
Mr. Gregory Brown BSc, MBA CEO, MD & Director 1964
Dr. Aloys Mbala Co-Founder NA
Mr. Ali Ghasemzadeh Co-Founder NA
Mr. Ura Phillip Stephen Auckland CFO & Company Secretary NA
Mr. Arun Bahadur Singh COO, CTO (CT), President of US & Europe Division and Executive Director 1959
Mr. S. Turner Dean Chief Sales Officer NA
Ms. Vinti Singh Vice President of Marketing NA
Dr. Yu Peng B.S., Ph.D. Chief Technology Officer (AI) NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.